CV

 
 

I am a passionate scientist with ten years of experience in the biological sciences and four years of experience in a pharmaceutical regulatory environment with the British Columbia government. I have developed and maintained extensive knowledge of provincial and national drug review processes; the reimbursement landscape; and legislation, regulations, and policies that impact the pharmaceutical industry. I have established strong collaborative working relationships with drug plan managers, policy makers, external experts, and patient groups in British Columbia and at the national drug review and negotiation level. I aim to use my personal and professional experience to positively impact the lives around me.

WORK EXPERIENCE

2022 - (current): Director of Precision Medicine and Genetic Services

  • Creates strategic plans, determines project objectives, manages the creation and delivery of project plans, and leads provincial and national consultations on policy development and strategies

  • Maintains collaborative relationships with government and industry stakeholders

  • Solves complex issues and provides advice and options for senior executives that support the provision of transparent, cost-effective, and appropriate novel therapeutic and genomics services for patients and their families

  • Member of the senior management Therapeutic Assessment and Access Leadership Team

  • Provide policy and issues-management advice regarding cell and gene therapies, genetic testing, and genetic workforce planning

  • Work effectively as a leader with a variety of internal (e.g., Research and Innovation, Health Technology Assessment) and external stakeholders (e.g., Genome BC, Genome Canada, University of Victoria, University of British Columbia)

  • Support pan Canadian Pharmaceutical Alliance negotiations, facilitate stakeholder engagements, resolve conflicts between stakeholders

  • Directly supervise a team of five

2020 - 2022: Drug Review Process Manager

  • Oversaw the review of approximately 90 drug products for addition to the BC PharmaCare formulary spanning several therapeutic areas

  • Developed strong working relationships with colleagues in BC formulary management, with jurisdictional counterparts, with representatives at CADTH and pCPA, and with external stakeholders including healthcare professionals and patient groups.

  • Developed and maintained a strong understanding of the Canadian drug reimbursement landscape and drug review processes

  • Supported the business team with scientific support and interpretation of clinical, pharmacoeconomic, and budget impact data submitted by manufacturers and from CADTH

  • Oversaw the identification and engagement of regional external experts and patient groups

  • Additional independent contributions include supporting drug price negotiations, managing contracts, supervising and training staff, and contributing to the planning and implementation of strategic initiatives

2019 - 2020: Technical Writer

  • Led a project developing comprehensive website content outlining the Canadian drug review process with content tailored to varying audiences

  • Developed pharmaceutical communications for drug product reviews and provincial formulary listings

2014 - 2019: PhD Student

  • Researched, collected, and communicated clinical, scientific, and technical information through review of scientific literature and attendance of conferences.

  • Developed and maintained extensive knowledge of the immune system and its relation to the pathophysiology of disease

  • Established and maintained professional relationships with academic and clinical leaders

EDUCATION

PhD NEUROSCIENCE | University of Calgary | 2014 - 2019 | GPA: 3.90

BSc BIOLOGY | Thompson Rivers University | 2009 - 2014 | GPA: 3.83

PUBLICATIONS

“Advancing the quintuple aim of healthcare improvement through the integration of genetic counselors into primary care”

“Help or harm? How immune cells of the brain balance the immune response”

“How to counteract age when the nervous system is damaged”

“Does myelin contribute to sex differences in depression?”

“The new techniques driving psychiatric research”

“A clinical trial will test exercise for multiple sclerosis”

“Mechanisms of LPC induced demyelination: a primary lipid disrupting myelinopathy”

“Microglia diversity in health and multiple sclerosis”

“Immunosenescence of microglia and macrophages: impact on the aging central nervous system”

“Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion”

“Multimodal enhancement of remyelination by exercise with a pivotal role for oligodendroglial PGC1alpha”

“Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system”

“Aging-exacerbated acute axon and myelin injury is associated with microglia-derived reactive oxygen species and is alleviated by the generic medication indapamide”

PANEL APPEARANCES

Genomics and Society Symposium: Foresight in Food, Human Health, and the Environment (Victoria)

Latest Developments in Value-Based Contracting Solutions (Basel, Switzerland)

Beyond the Promise: Maximizing Value for Patients (Vancouver)

Access to Innovation (Vancouver)